Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Symmetry Medical Inc Announces FDA Clearance of Its FLASH PAK Evolution Valve
Symmetry Medical Inc announced that it received United States Food and Drug Administration (FDA) 510K clearance for its FLASH PAK Evolution valve. The Evolution valve is the next generation valve for Symmetry's immediate use (flash) sterilization product, FLASH PAK, and is distributed exclusively through Symmetry Surgical. The patent pending stainless steel construction of the new valve is designed for ease of use and simplicity of care.
Latest Developments for Symmetry Medical Inc
Latest Key Developments in Medical
- Share this
- Link this
- Digg this
Follow Reuters